In 2015, HHS designated Denver Health one of 13 Regional Emerging Special Pathogens Treatment Centers in the U.S. — serving as an infectious disease training and care hub for six states in its region.
It is one of the first health systems in the country to administer the vaccine, according to the news outlet.
The vaccine, Ervebo, was first approved by the FDA in 2019 for anyone older than 1.
While outbreaks have continued across the globe, Ebola is less frequently seen in the U.S. but nonetheless is extremely deadly with a mortality rate between 70% and 90% when left untreated, according to the CDC.
“Importation of Ebola disease to the United States by an infected traveler from an outbreak area is a recognized risk with the potential for spread to other people,” the CDC states. “During the 2014-2016 Ebola disease outbreak in West Africa, 11 people were treated for [Ebola] in the U.S., and two of them died. Nine of these cases were imported into the U.S.”
The other two cases were contracted by healthcare workers treating the patients, according to the agency.
It is unclear how long the vaccines provide immunity, but at the moment the dosage is just one shot, Maria Frank, MD, a hospital medicine specialist with Denver Health, told 9News.
She was one of the first recipients of the vaccine, which at this time is only available to frontline workers at high risk of contracting the disease.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
